The possible discrepancy bctween the dose level required for promoting action (when given after the initiation process, and that needed to exert an anticarcinogenic effect when given simultaneously with a carcinogen) of hepatic promoters were investigated in an attempt to obtain a "practical" threshold dose of promoters. Phenobarbital (PB) and dichlorophenyltrichlorethane (DDT) were used as promoters and 3'-methyl-4-(dimethylamino)-azobenzene (3I-Me-DAB) was used as the carcinogen. Male weanling rats were treated with either 600 ppm 3'-Me-DAB for 3 weeks followed by a diet containing a promoter at various dose levels (5-500 ppm), or the animals were treated with a low dose (100 ppm) of 3'-Me-DAB plus a promoter at various dose levels (20-500 ppm). The effects of promoters were measured by scoring size and number of enzyme-altered islands (EAIs) at 12 and 24 weeks of age. The promoting effect of PB and DDT was demonstrated in dose-dependent fashion, in the dose range of 10-500 ppm and 20-500 ppm, respectively. On the other hand, promoters given simultaneously with a low dose of carcinogen enhanced carcinogenesis at all the dose levels tested, in contrast with the inhibitory effect on carcinogenesis when given together with relatively high doses of carcinogens. at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from 310 KITAGA WA TOXICOLOGIC PATHOLOGY ( 0 t / 2/29 Phenobarbital (0.051) 30 7 : 36 Weeks 4 L = 12 -18 -L" 24 FIG. 1 .-Cumulative incidence of serum a-fetoproteinpositive rats during 3'-Me-DAB feeding with or without PB. The anticarcinogenic effect on the simultaneous administration of PB is remarkable.
lem. The effects of promoters were measured quantitatively by scoring the number and size of EAIs. EAIs are cloned proliferated progenies of initiated cells (1 7) developing in the early phase of carcinogenesis and at a thousand times greater frequency than tumors. It has been shown by this and other laboratories (4, 15, 19, 24) that the EAI-system enables rapid and precise analysis of the effects of initiation and promotion.
METHODS

Atiitnals and Adtnitiistration Sclieditle for Stiidyirig the Promoting Eflects of PB arid DDT. Male
Donryu rats (Nihon Rat Co., Urawa) 21 days old were used. They were housed five per plastic cage in an air-conditioned room under a natural lightdark cycle and given food and water freely. They were fed a basal diet (CE-11, CLEA Inc., Tokyo) containing 600 ppm 3I-Me-DAB for the initial 3 weeks and then a diet containing PB (Iwaki Seiyaku Co., Tokyo) or DDT (Tokyo Kasei Co., Tokyo, technical grade) at various doses, ranging from 5 to 500 ppm, continuously. Five animals 12 weeks of age and six to 10 animals 24 weeks of age per group were sacrificed.
Atiinials atid Adtnitiistration Schediile for Stiidyirig the Eflect of PB atid DDT Given Siniiiltatieoiisly with 3'-A!fe-DAB.
Twenty-one-day-old male Don-ryu rats and male Fisher rats (Nihon Charles River Co., Atsugi) were used for the experiment with PB and DDT. The housing conditions were the same as described above. The animals were given a basal diet (CE-11) containing 100 ppm 3'-Me-DAB and various doses of PB or DDT at various levels as indicated in Tables I1 and 111 . Five animals at 12 weeks of age and four or five animals at 24 weeks of age were sacrificed.
Histochemical Denionstration of EAI and Scoring. The liver was sliced at intervals of 5 mm. A11 the slices were arranged side by side on four pieces of filter paper, with cross sections facing up, and frozen on dry ice. Cryostat sections were made at a thickness of 12 pm and were taken from different levels about 1 mm apart from each other. Since only a limited number of EAIs developing by week 24 after promotion exceeded 1 mm in size (Figs. 3 and 4) and almost all the EAIs observed in the liver simultaneously treated with a promoter and 100 ppm 3'-Me-DAB were less than 500 pm in diameter, interference by duplicated sectioning of the same EAI was negligible. Twelve to 16 sections, each section area measuring 4.5 to 5.0 cm2, were made from each liver and used for scoring. The sections were fixed in cold formol calcium over night and stained for canalicular ATPase (23) and size and/or number of ATPase-deficient islands were measured utilizing an eye piece grid in the microscope.
RESULTS
The results of the experiments recording the promoting effects of PB and DDT are shown in Figs. 2 and 3 and in 4 and 5 , respectively. The number of animals studied at week 12 were five per group and only the number of EAIs was scored, whereas at week 24, the number of animals investigated was larger, and both the number and size of EAIs were measured. Therefore, the data from week 24 are more comprehensive.
As seen in Fig. 3 , PB clearly showed a dose-dependent promoting effect both on the number and size of EAIs within the 10 to 500 ppm dose range investigated. Although 5 ppm PB appears also to have increased the total number of EAIs, the figure is not significantly different from that of the 0 ppm control group. The increase in the total number of EAIs in the 10-500 ppm groups is significant (p < 0.05 or 0.01). The numbers of EAI belonging to the largest size class are significantly increased in the 0.1 1 +-0.09 (5) 0.63 f 0.12 ( 100 and 500 ppm groups (p < 0.05 and p < 0.0 1, respectively), and those belonging to the next two largest size classes are significantly increased in the 20-500 ppm groups (g < 0.1-0.01).
With DDT there was also a dose-related effect, both on the number and size of EAIs. The total numbers of EAIs are significantly (p < 0.01) increased in every dose group, except for that given 10 ppm. The increase in the number of EAI belonging to the largest two size classes in the 100 and 500 ppm groups is significant (p < 0.05-0.10) and that of the third size class is significant in all the dose groups (p < 0.1-0.0 1).
The data concerning the effects of PB or DDT given simultaneously with 100 ppm 3'-Me-DAB are shown in Tables I1 and 111 . The number of EAIs are larger in all the groups treated with PB or DDT, at both weeks 12 and 24, indicating the enhancing effect of these promoters on carcinogenesis. An approximate dose dependency in this effect is evident. The differences between the figures of experimental groups and those of controls are mostly significant, as indicated in the Tables, It is of note that in Fig. 2 the total number of EAIs in animals treated with 500 ppm PB at week 12 and those of animals treated with 100 ppm PB at week 24 are about the same as those of animals treated with 500 ppm PB at week 24. This result is in contrast with the results of DDT administration (Fig. 4) where the number of EAIs of animals fed 500 ppm DDT at week 24 is significantly larger than those of any other groups.
There were a small number of background EAIs in the liver of animals treated only with 500 ppm PB or DDT from week 3 to week 24 (Tables I1 and  111 ). The average number of EAIs/cmz of these animals at week 24 was 0.18 * 0.08 and 0.21 * 0.25, respectively.
DISCUSSION
The present experiments have shown that a promoting effect of PB and DDT is seen at levels as low as 10 to 20 ppm and that, quite unexpectedly, these compounds when given simultaneously with 3'-Me-DAB enhance carcinogenesis at every dose tested (20-500 pprn), when the (level of carcinogen is low. Consequently, our original aim of attaining a practical threshold level was {ot feasible.
Previously Peraino et a1 (1 3) made a dose-related study on the promoting effect of PB in acetylaminofluorene (AAF')-initiated rat hepatocarcinogenesis and found that 20 ppm PB, thd lowest Ievel tested, slightly increased the number, gut not the size, of tumors. Takano et a1 (18) also found a slight, although statistically not significant, increase ofAAFinitiated EAIs by feeding 20 ppm PB for 6 weeks. Goldsworthy et a1 (1 2), on the other hand, found no promoting effect of PB below 10 ppm with regard to the number of EAIs developing after initiation by diethylnitrosamine (DEN). A report from the Week 24 100 100
0.12 f 0.15 (5) 2.10 f 0.54 (5)" Same laboratory, however, previously described that PB at as low a level as 0.5 ppm increased the number, but not the size, of EAIs (1). Apparently more studies are needed to clarify the promoting effect of PB at low dose levels. It should be kept in mind, however, that there may be differences between initiators with regard to the biological character of their initiated hepatocytes which could interfere with the result. As was previously shown in this laboratory (4), DEN-induced EAIs are generally more potent in growing and progressing spontaneously carcinomas, that is without the aid of promotion, than those induced by 3'-Me-DAB, and consequently the effect of promotion was more clearly detectable when 3'-Me-DAB was used as an initiator. DDT also demonstrated a dose-dependent enhancing effect at week 24 but this was less clear than PB at low dose levels around 10 ppm. The reason why there was a difference in the basic frequency of EAIs between PB and DDT experiments is not clear. Since the two experiments were carried out at separate times, there may have been some differences in the experimental condition, especially in the age of the weanling animals at the start of the experiment.
Formerly, Tomatis (21) reported that 2-10 ppm DDT increased the number of liver cell tumors in CFI mice. According to Peraino et a1 (12), 500 ppm DDT showed a similar promoting effect to the 500 ppm PB on AAF-initiated tumorigenesis in rats. In the present experiment, however, DDT appeared to be a less potent promoter than PB: the effects of 100 and 500 ppm DDT were not very remarkable by weeks 24 and 12, respectively, whereas those of 100 and 500 ppm PB were fully expressed by weeks 24 and 12, respectively.
It is of note that the number of EAIs in the 500 ppm PB group at week 12 is about the same as in the 100 and 500 ppm PB groups at week 24. This finding confirms our previous observation (4), and may indicate that when promoted by 500 ppm PB almost all initiated cells proliferate to form EAIs larger than 50 pm by week 12 and persist thereafter. There is no evidence for suspecting that the data might reveal only the balance between the appearance and disappearance of EAIs. Goldsworthy et a1 also recently presented data indicating the irreversible nature of EAIs (2).
The discovery of the cocarcinogenic effect of promoters when 100 ppm 3I-Me-DAB was given simultaneously was quite unexpected. As described in the Introduction, when we treated animals with 600 ppm 3'-Me-DAB, the simultaneous administration of 500 ppm PB remarkably reduced the number of EAIs and the subsequent cancer development. In the present experiment, we reduced the dose of carcinogen because the effect of low dose PB was not visible at high (600 ppm) doses of 3I-Me-DAB (data not shown). It is conceivable that at a high dose of carcinogen, the promoter-elevated activity of the drug metabolizing system may work quite efficiently for detoxification of the carcinogen. It may also markedly reduce both the initiation rate and the toxicity-dependent promoting action of the carcinogen, the resulting effect being anticarcinogenic. At relatively low doses of carcinogens, however, detoxification of carcinogens may be effectively achieved by the original level of detoxifying enzymes and only the original promoting action of promoters may predominate. This aspect is important because exposure of human beings to environmental carcinogens and promoters is practically always at low levels.
Recently, Pereira et a1 reported (1 4) that concurrent administration of 500 ppm PB with DEN increased the number and size of r-glutamyltranspeptidase-positive foci (a type of EAI). Since they treated the animals by weekly injection of DEN, which is known to be metabolized and excreted from the body within a day, they may have observed the promotive aspect of PB on DEN-initiated cells in their experiments. The combined effect of carcinogens, promoters, and anticarcinogens should be carefully studied at various experimental conditions.
